- Home
- BEATW vs REGCP Comparison
BEATW vs REGCP Comparison
Compare BEATW & REGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- REGCP
- Stock Information
- Founded
- BEATW 2015
- REGCP N/A
- Country
- BEATW United States
- REGCP United States
- Employees
- BEATW 21
- REGCP 497
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- REGCP
- Sector
- BEATW Technology
- REGCP
- Exchange
- BEATW Nasdaq
- REGCP Nasdaq
- Market Cap
- BEATW N/A
- REGCP N/A
- IPO Year
- BEATW N/A
- REGCP N/A
- Fundamental
- Price
- BEATW $0.60
- REGCP $23.25
- Analyst Decision
- BEATW
- REGCP
- Analyst Count
- BEATW 0
- REGCP 0
- Target Price
- BEATW N/A
- REGCP N/A
- AVG Volume (30 Days)
- BEATW 4.7K
- REGCP N/A
- Earning Date
- BEATW 03-14-2025
- REGCP N/A
- Dividend Yield
- BEATW N/A
- REGCP N/A
- EPS Growth
- BEATW N/A
- REGCP N/A
- EPS
- BEATW N/A
- REGCP N/A
- Revenue
- BEATW N/A
- REGCP N/A
- Revenue This Year
- BEATW N/A
- REGCP N/A
- Revenue Next Year
- BEATW N/A
- REGCP N/A
- P/E Ratio
- BEATW N/A
- REGCP N/A
- Revenue Growth
- BEATW N/A
- REGCP N/A
- 52 Week Low
- BEATW $0.50
- REGCP N/A
- 52 Week High
- BEATW $0.62
- REGCP N/A
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- REGCP 52.73
- Support Level
- BEATW N/A
- REGCP $22.32
- Resistance Level
- BEATW N/A
- REGCP $23.54
- Average True Range (ATR)
- BEATW 0.00
- REGCP 0.34
- MACD
- BEATW 0.00
- REGCP 0.08
- Stochastic Oscillator
- BEATW 0.00
- REGCP 82.35
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About REGCP Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.